Page last updated: 2024-11-03

prazosin and Hemorrhagic Fever, Ebola

prazosin has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Hemorrhagic Fever, Ebola: A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Selaković, Ž1
Tran, JP1
Kota, KP1
Lazić, M1
Retterer, C1
Besch, R1
Panchal, RG1
Soloveva, V1
Sean, VA1
Jay, WB1
Pavić, A1
Verbić, T1
Vasiljević, B1
Kuehl, K1
Duplantier, AJ1
Bavari, S1
Mudhasani, R1
Šolaja, BA1

Other Studies

1 other study available for prazosin and Hemorrhagic Fever, Ebola

ArticleYear
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
    European journal of medicinal chemistry, 2019, Jan-15, Volume: 162

    Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface

2019